Limited studies suggest that during embryonic vasculogenesis and sprouting angiogenesis, anastomosis is accomplished via connection of extended cellular processes followed by lumen propagation through intra-and inter-cellular vacuole fusion 10,11 with macrophages playing an accessory role 12 . However, it is not known whether this is the only mechanism for connecting vessels. Without a basic understanding of the cellular mechanisms of anastomosis, it is difficult to develop strategies for accelerating this critical step for perfusing engrafted tissues. To investigate the process of anastomosis, we used a previously-established model in which
HUVECs and mouse mesenchymal precursor cells are embedded in collagen-fibronectin gels and placed in cranial window preparations of severe combined immunodeficient (SCID) mice 2 (Supplementary Figure 1) . In this system, anastomosis between host vessels and implanted EC networks occurs as early as two weeks after implantation, and the engineered vessels remain stable and functional for one year in vivo 2 . Similar results can be achieved when the mouse mesenchymal precursor cells are replaced with human mesenchymal stem cells 13 or human lung fibroblasts 14, 15 . Tracking fluorescently-labeled implanted ECs and host ECs simultaneously in live animals, we found that end-to-end connections and vacuole fusion were not involved in host-implant vascular anastomosis; surprisingly, the engrafted endothelial networks wrapped around host vessels at the host-implant interface and then replaced sections of the underlying vessel wall to tap into the host blood supply. After overnight incubation, the 293ET cells were washed with PBS and replaced with fresh media. The next day, the supernatant containing retrovirus was collected and fresh medium was added; this step was repeated three more times. After the supernatant was collected, it was passed through a 0.45 μm filter (Whatman, Middlesex, UK) and was either used immediately or kept at -80 °C.
For the transduction, the supernatant was first diluted 1:1 with fresh cell culture medium and supplemented with polybrene (8 μg/ml). The diluted supernatant was then added to a subconfluent monolayer of cells and allowed to incubate for 4 hours. Fresh cell culture medium was exchanged at the end of the incubation period and this step was repeated two to three times on consecutive days. By comparing fluorescent images of GFP-transduced HUVECs to
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From human CD31 staining, we confirmed that more than 90% of cells were effectively labelled for intravital imaging (Supplementary Figure 2b) .
Because PMBECs were difficult to label ex vivo, we used endogenous expression of GFP driven by the Tie2 promoter to distinguish implanted from host PMBECs. Implantation of PMBECs was performed between Tie2-GFP/Rag1 -/-and Rag1 -/-mice (both eight weeks old).
The Tie2-GFP/Rag1 -/-mice were created by crossing Tie2-GFP mice with Rag1 -/-mice (both from Jackson Laboratory, Bar Harbor, ME).
For PMBEC isolation, animal cerebrocortices were first cut into small pieces, homogenized and diluted with Dextran/PBS to a final concentration of 15% (v/v). Homogenate was centrifuged at 10,000g and 4 °C for 15 minutes. The resulting pellet was digested with collagenase/dispase at 1 mg/ml in MCDB131 with 2% FBS for 3 hours at 37 °C with constant shaking. The digested tissues were subsequently resuspended with percoll/PBS to a final concentration of 45%
(v/v). Tissues were then centrifuged at 20,000g and 4 °C for 10 minutes. Supernatant containing vessel fragments was saved, washed once with PBS, resuspended with PMBEC medium and plated on fibronectin-coated plates. All PMBECs were implanted at passage zero. g  e  n  g  e  l  s  e  m  b  e  d  d  e  d  w  i  t  h  c  e  l  l  s   8 x 10 5 HUVECs or PMBECs and 2 x 10 5 10T1/2 cells were suspended in 1 ml of a solution of rat-tail type 1 collagen (1.5 mg/ml; BD Biosciences, Bedford, MA) mixed with human plasma fibronectin (90 μg/ml; Sigma) in EGM or PMBEC medium at 4 °C. pH was adjusted to 7.6 using 1N NaOH. The cell suspension was pipetted into 12 well plates (BD Biosciences) and warmed to 37 °C for 30 min to allow collagen polymerization. Each solidified gel construct was covered by 2 ml of warmed EGM or PMBEC medium. After 18~24 hrs of culture at 37 °C and 5% CO 2 , a 4 mm biopsy punch was used to cut disk-shaped pieces of the gel construct; these were implanted into mouse cranial windows 16 as described previously 2 . Dorsal skinfold chambers were created as previously described 17 . For gel construct implantation, the cover glass on the chamber was removed and the disk-shaped gel construct was placed directly on top of the For personal use only. on November 16, 2017. by guest www.bloodjournal.org From tissue. The chamber was then sealed again with the cover glass and a metal tension ring. Care was taken and saline solution was applied to prevent the formation of air bubbles inside the chamber during this procedure.
A Fluoview 500 confocal laser-scanning microscope (Olympus America, Center Valley, PA) was used for intravital microscopy. During the imaging, the animal's head was stabilized with a custom-made cranial window holder, its body was placed on a heating pad with circulating 37
°C water (Paragon Medical, Pierceton, IN) and anesthesia was maintained with a table-top isofluorane anesthesia system (VetEquip, Pleasanton, CA).
To visualize the host vasculature in mice implanted with HUVECs, azide-free and low-endotoxin mouse-specific CD31 antibody (BD Biosciences Pharmingen, San Diego, CA) was labeled using an Alexa®647 (referred to here as X647) antibody labelling kit (Invitrogen) and then injected intravenously. The antibody, mCD31-X647, was allowed ~5 min to circulate before imaging started. This treatment was very well tolerated by the animal and the fluorescence from vessel-bound mCD31-X647antibody persisted for ~3 days. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From paraformaldehyde in PBS through cardiac puncture. The cover glass forming the cranial window was then removed and the implanted collagen gel (~300 μm in thickness) was harvested and put into 4% paraformaldehyde in PBS to be fixed for 1.5 hrs on ice. For immunohistochemical (IHC) staining, the fixed collagen gels were washed with 1X PBS 3 times, 10 min each, blocked with 3% BSA+0.1% Triton X100 for 1 hr, incubated with primary antibodies at 4 °C overnight, and washed with 1X PBS+0.1% Triton X100 for 10 min, 3 times. The sample was then incubated with secondary antibodies at room temperature for 4 hr or at 4 °C overnight, and washed again with 1X PBS+0.1% Triton X100 for 10 min 3 times. The collagen gels were then mounted directly on glass slides and covered with mounting media (Vector Laboratories, Burlingame, CA) and a cover glass for imaging. The primary antibodies used were rat anti- Images were analyzed with code developed in-house using Matlab (MathWorks, Natick, MA).
Operations were performed on confocal images of MMP-14/MMP-9 staining and HUVECs.
Multiple rectangular regions of interest (ROIs) were placed at random positions in the HUVEC network, each locally orthogonal to, and overlapping with, the vessel segment; ROIs were 40µm in length and extended 50µm past the vessel wall on both sides. For each ROI, segmentation was performed to identify the HUVEC-positive pixels and, within this area, the average intensity of the corresponding MMP-9 or MMP-14 signal was recorded. The local vessel diameter was also calculated within each ROI, and the wrapping status recorded (i.e., "wrapped" or "not wrapped"). In each field, all intensity data were normalized to the average level associated with wrapped HUVECs, which served as the internal standard. Thus, each data point in Figures 4e and 4f represents the intensity within a given ROI divided by the field-averaged, wrapped vessel intensity. Analysis of expression by other cell types followed a similar procedure. Fluorescently-conjugated dextran was injected intravenously into the animal and confocal image stacks were acquired of both the implanted vessels and the dextran. Image projections were then processed by Matlab (MathWorks) and the perfused fraction was calculated as the ratio of the projected area with dextran over the projected area of all the implanted vessels. 
Performing intravital confocal microscopy on gels implanted in cranial windows, we found that We next examined the structure of the wrapped vessel segments, focusing first on pericytes, which are known to provide structural integrity and survival factors to blood vessels, making them refractory to remodeling [21] [22] [23] . Since the expression of pericyte markers, including Suspecting that the tapping process also requires the degradation of host vessel basement membrane (BM), we next analyzed the distribution of collagen IV, a major component of the BM, around wrapped vessels. Normal, unwrapped host vessels were ensheathed in a thin, compact layer of BM (Figure 3a , "Normal host"). This structure was dramatically disrupted by the wrapping HUVECs, which in many regions were directly adjacent to the underlying host ECs, separating them from the BM (Figure 3a , "Wrapped host"). This observation is further confirmed by quantification of the spatial distribution of collagen IV around normal and wrapped host vessels (Figure 3b and 3c ).
Since rearrangement of the BM generally requires matrix metalloproteinases (MMPs), we HUVEC MMP levels returned to baseline.
To determine whether MMP activity is necessary for host vessel degradation during WAT anastomosis, we treated animals with GM6001, a broad-spectrum MMP inhibitor. After waiting for the engrafted HUVECs to wrap around many of the host vessels (9 days), we started treatment and then tracked eight to nine pre-wrapped host vessel segments in the cranial window for two weeks. This procedure allowed us to focus specifically on MMP-involvement in host vessel degradation by wrapping HUVECs, rather than other processes such as EC migration or lumenogenesis. GM6001 treatment significantly reduced the degradation of the underlying host segments, allowing many of the wrapped, bilayer structures to persist. The percentage of wrapped host segments that had degraded was 68.1±6.3% in control animals, and 38.9±9.6% in those treated with GM6001 (p<0.05; see also Supplementary Figure 5e ). To further investigate the roles of MMP-14 and MMP-9 in WAT anastomosis, we treated animals with monoclonal antibodies against MMP-14 (DX-2400) and/or MMP-9 (DX-2802) every other day for 6 weeks and quantified the fraction of HUVEC network that was perfused during this period (see details in METHODS). Blocking either MMP-14 or MMP-9 significantly suppressed perfusion of the HUVEC network during the first four weeks after implantation, and there was an additional reduction with simultaneous inhibition of both MMPs (Figure 4g and 4h) . However, the effect of MMP inhibition gradually diminished, and the difference was only significant between the control group and the group treated with both antibodies at six weeks after implantation.
Therefore, it is possible that activation of other gelatinases can compensate for the loss of MMP-14 and MMP-9 activity.
Considering the complex cellular interactions required by WAT anastomosis, it would be surprising if the host endothelial barrier were maintained throughout the process. Although for the most part this seemed to be achieved, we did observe transient increases in vessel leakiness in wrapped host vessels (Supplementary Figure 5f , see also Supplementary Movie 7).
Such transient plasma leaks were not observed in normal host vessels under similar imaging conditions.
To verify that WAT anastomosis is not an artifact of xenografting human ECs into mice, we repeated the experiment with syngeneic primary murine brain endothelial cells (PMBECs). We 
